News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
790,617 Results
Type
Article (82532)
Company Profile (399)
Press Release (707684)
Multimedia
Podcasts (131)
Webinars (17)
Section
Business (209876)
Career Advice (3530)
Deals (37883)
Drug Delivery (128)
Drug Development (88777)
Employer Resources (187)
FDA (17765)
Job Trends (16585)
News (367128)
Policy (38044)
Tag
Academia (2998)
Academic (1)
Accelerated approval (7)
Adcomms (32)
Allergies (101)
Alliances (54007)
ALS (112)
Alzheimer's disease (1534)
Antibody-drug conjugate (ADC) (182)
Approvals (17713)
Artificial intelligence (342)
Autoimmune disease (32)
Automation (18)
Bankruptcy (384)
Best Places to Work (12505)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (269)
Bladder cancer (95)
Brain cancer (36)
Breast cancer (370)
Cancer (2881)
Cardiovascular disease (232)
Career advice (2996)
Career pathing (34)
CAR-T (200)
CDC (33)
Cell therapy (540)
Cervical cancer (23)
Clinical research (72191)
Collaboration (1033)
Company closure (3)
Compensation (648)
Complete response letters (30)
COVID-19 (2888)
CRISPR (64)
C-suite (314)
Cystic fibrosis (116)
Data (2855)
Decentralized trials (2)
Denatured (43)
Depression (64)
Diabetes (326)
Diagnostics (6880)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (122)
Earnings (81831)
Editorial (48)
Employer branding (25)
Employer resources (162)
Events (118129)
Executive appointments (877)
FDA (19347)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (926)
Gene editing (141)
Generative AI (28)
Gene therapy (413)
GLP-1 (894)
Government (5141)
Grass and pollen (6)
Guidances (179)
Healthcare (20740)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (170)
Immuno-oncology (8)
Indications (36)
Infectious disease (3063)
Inflammatory bowel disease (162)
Inflation Reduction Act (11)
Influenza (63)
Intellectual property (114)
Interviews (673)
IPO (17542)
IRA (52)
Job creations (4525)
Job search strategy (2462)
Kidney cancer (14)
Labor market (48)
Layoffs (581)
Leadership (25)
Legal (9458)
Liver cancer (83)
Lung cancer (412)
Lymphoma (200)
Machine learning (9)
Management (64)
Manufacturing (398)
MASH (92)
Medical device (14551)
Medtech (14556)
Mergers & acquisitions (21028)
Metabolic disorders (874)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (131)
Neuropsychiatric disorders (37)
Neuroscience (2234)
NextGen: Class of 2025 (7459)
Non-profit (5065)
Now hiring (44)
Obesity (464)
Opinion (284)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (111)
Parkinson's disease (188)
Partnered (25)
Patents (293)
Patient recruitment (142)
Peanut (53)
People (62018)
Pharmaceutical (89)
Pharmacy benefit managers (24)
Phase I (22183)
Phase II (31390)
Phase III (23704)
Pipeline (1598)
Policy (214)
Postmarket research (3437)
Preclinical (10006)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (489)
Real estate (6855)
Recruiting (75)
Regulatory (25994)
Reports (50)
Research institute (2653)
Resumes & cover letters (563)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (23)
Sickle cell disease (63)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4066)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (86)
Vaccines (871)
Venture capitalists (51)
Weight loss (314)
Women's health (46)
Worklife (20)
Date
Today (144)
Last 7 days (553)
Last 30 days (2590)
Last 365 days (33879)
2025 (16070)
2024 (37384)
2023 (42305)
2022 (53601)
2021 (58329)
2020 (57264)
2019 (50913)
2018 (38778)
2017 (36332)
2016 (36531)
2015 (42191)
2014 (35700)
2013 (33325)
2012 (33744)
2011 (34048)
2010 (33816)
Location
Africa (1156)
Alabama (64)
Alaska (7)
Arizona (248)
Arkansas (14)
Asia (47293)
Australia (8323)
California (7329)
Canada (2279)
China (675)
Colorado (315)
Connecticut (333)
Delaware (187)
Europe (110120)
Florida (1098)
Georgia (247)
Hawaii (1)
Idaho (65)
Illinois (679)
India (29)
Indiana (359)
Iowa (17)
Japan (218)
Kansas (114)
Kentucky (29)
Louisiana (16)
Maine (73)
Maryland (1055)
Massachusetts (5574)
Michigan (252)
Minnesota (458)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (25)
Nevada (79)
New Hampshire (71)
New Jersey (2056)
New Mexico (31)
New York (2075)
North Carolina (1182)
North Dakota (10)
Northern California (3201)
Ohio (238)
Oklahoma (16)
Oregon (38)
Pennsylvania (1577)
Puerto Rico (17)
Rhode Island (39)
South America (1535)
South Carolina (34)
South Dakota (1)
Southern California (2723)
Tennessee (121)
Texas (1098)
United States (27639)
Utah (220)
Virginia (191)
Washington D.C. (78)
Washington State (637)
West Virginia (4)
Wisconsin (76)
790,617 Results for "st jude children s research hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
BioLineRx Announces Clinical Trial Agreement with St. Jude Children’s Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
BioLineRx Ltd. today announced a multi-center Phase 1 clinical trial sponsored by St. Jude Children’s Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).
May 30, 2024
·
8 min read
Press Releases
Alfred E. Mann Charities Gives $12 Million for Cell and Gene Therapy Research at Children’s Hospital Los Angeles
May 21, 2025
·
4 min read
Press Releases
Acuitas Therapeutics Showcases Collaboration with Children’s Hospital of Philadelphia for Personalized CRISPR Therapy and New LNP Research at ASGCT 2025
May 16, 2025
·
6 min read
Press Releases
New Research from Children’s Hospital of Philadelphia and St. Jude Poised to Transform Approach to Diagnosing and Treating Acute Leukemia in Children
August 15, 2024
·
7 min read
Drug Development
CalciMedica Collaborator St. Jude Children’s Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
CalciMedica Inc. today announced that its collaborator, St. Jude Children’s Research Hospital (SJCRH), presented data from the initial cohort of the Phase 1/2 CRSPA study of Auxora™ (zegocractin injectable emulsion) in asparaginase-induced pancreatic toxicity (AIPT).
December 11, 2023
·
9 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
May 7, 2025
·
4 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Develop Promising Tools to Enhance Gene Therapy Delivery for Hard-to-Treat Diseases
May 20, 2025
·
5 min read
Press Releases
Children’s Hospital Los Angeles Team Is First in World to Investigate Cardiac Xenotransplant as a ‘Bridge’ for Babies
April 29, 2025
·
5 min read
Phi Delta Chi announces second $1M pledge to St. Jude Children’s Research Hospital
On the heels of fulfilling a $1 million pledge to St. Jude Children’s Research Hospital ® two years ahead of schedule, professional pharmacy fraternity Phi Delta Chi is ready to do it again.
December 1, 2022
·
3 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Develop Cell Atlas to Uncover Significant Shifts in the Neuroblastoma Tumor Microenvironment
April 14, 2025
·
5 min read
1 of 79,062
Next
